ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis

por Chiu, Kuo-Liang, Lin, Yu-Sen, Kuo, Ting-Ting, Lo, Chia-Chien, Huang, Yu-Kai, Chang, Hsien-Fang, Chuang, Eric Y., Lin, Ching-Chan, Cheng, Wei-Chung, Liu, Yen-Nien, Lai, Liang-Chuan, Sher, Yuh-Pyng
Publicado 2017